FDA to consider US switch for Nasacort AQ

1 July 2013 - Deborah Wilkes

Archived

Sanofi's Nasacort AQ (triamcinolone acetonide) nasal spray could soon be switched from prescription-to-OTC status in the US.

Click tags below for more information on topics:

FDA

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: